CancerQR · Next generation cancer therapies targeting cancer networks

Pattern BioSciences is an ETH Zurich Spin-Off and an innovative biotechnology start up that proposes a paradigm shiftingapproach towards tailored and customizable cancer therapies. The company is commercializing the disruptive ""Networkagainst Network"" approach to cancer therapies, which takes into account tumor complexity and probes and targets tumorcells at multiple points of tumor molecular network. The therapies will be more efficacious, less toxic and less prone to drugresistance compared to the state of the art treatments. Building on large IP portfolio and extensive expertise and know-howof its founders, the company proposes this feasibility study to assess the commercialization potential of its offering viaintensive partner search, stakeholder alignment, freedom to operate analysis, and formulating IPR and knowledgemanagement strategy. With company's current Minimal Viable Product (MVP) at TRL 6, interaction with prospective parters during thisfeasibility study will define the set of Customizable Therapeutic Prototypes (CTPs) at TRL 9, conducive to entering into partnership deals. Delivering CTPs in the Phase II of the innovation action will enable the company to enter into large scale, long term partnershipagreements with established players in Pharma and Biotech industries and execute a European-wide growth and expansionplan, creating multiple jobs and strengthening Europe as an innovative Biotechnology hub.""